Intelligent Oral Suspension System for Baclofen

Publication ID: 24-11857524_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Oral Suspension System for Baclofen,” Published Technical Disclosure No. 24-11857524_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857524_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,524.

Summary of the Inventive Concept

A novel system integrating AI, IoT, blockchain, and advanced materials to ensure the stability and authenticity of oral suspensions of baclofen, enhancing patient safety and treatment outcomes.

Background and Problem Solved

The original patent provided stable oral suspensions of baclofen, but it did not address the need for real-time monitoring, automation, and verification of suspension stability and authenticity. The new inventive concept solves this problem by introducing synergistic combinations of distinct technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The system consists of a sensor for detecting pH levels and temperature fluctuations in the suspension, a microcontroller for processing data and adjusting the suspension composition accordingly, and a communication module for transmitting stability data to a remote monitoring platform. Additionally, the system incorporates machine learning algorithms for optimizing suspension stability, a blockchain-based ledger for tracking and verifying authenticity, and novel material compositions for enhanced bioavailability and stability.

Novelty and Inventive Step

The new claims introduce a synergistic combination of AI, IoT, blockchain, and advanced materials to create a more powerful system, which is not obvious from the original patent. The integration of these distinct technologies provides a novel solution for ensuring the stability and authenticity of oral suspensions of baclofen.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of sensors, machine learning algorithms, or blockchain platforms. Variations may also include integrating the system with existing pharmaceutical manufacturing processes or using different material compositions for the oral suspensions.

Potential Commercial Applications and Market

The intelligent oral suspension system has significant commercial potential in the pharmaceutical industry, particularly in the areas of neurological disorders, pain management, and pediatrics. The system's ability to ensure the stability and authenticity of oral suspensions can improve patient safety, reduce costs, and enhance treatment outcomes.

Original Patent Information

Patent NumberUS 11,857,524
TitleStable oral suspensions of baclofen
Assignee(s)ANI Pharmaceuticals, Inc.